This content is from: Patents

Medeva and Georgetown win in SPC rulings

The Court of Justice of the EU clarified the law on SPCs for combination drugs this morning, but included a sting in the tail for pharma companies

Get Free Access to read more …

To read the full article, activate your free trial.

Get Free Access
  • Unlimited articles for one week
  • No commitments; no payment details required
  • Featuring IP strategy, copyright, patents, trademark and more!

Are you a Managing IP subscriber? Simply login here.